»Ê¼Ò»ªÈË

Funding of up to £100,000 is available to provide additional support for clinical trials. The trials may be observational or interventional and may relate to either surgery or oncology.

This funding scheme helps UK-based primary bone cancer researchers to travel to national or international conferences.

Cancer Research UK fund exceptional scientists. Examples of funding include those for individual research, large-scale team programmes, multidisciplinary collaborations, and international consortia.

These grants are designed to go towards general organisation running costs. For example, they may be used for paying salaries and helping with bills and rent.

The Medical Research Council offer regular, continuous funding opportunities. Funding is available for groups and individuals in any scientific area relevant to the MRC.

These programmes fund projects that seek to build the skills and capabilities of young people.

The Sir Halley Stewart Trust are a grant-making charity supporting innovative and pioneering social, medical and religious projects, for the prevention of human suffering. These multi-year grants are normally given in the form of a salary contribution or to fund an entire project.

Provide funding to encourage and further medical research in a variety of areas. Applications are invited from doctors and research scientists and can be for either research in progress or prospective research.

This fellowship will enhance the knowledge and practical skills of pathologists whose focus of clinical work, research and education involves skeletal disease such as primary bone tumours, skeletal dysplasia, and metabolic disease.

These Transformational Research Awards support advanced pre-clinical translational research, clinical studies or trials to develop and test new treatments, diagnostics or other technologies, or for the establishment of the evidence required for the uptake of improved treatments or technologies into the NHS. Research funded through this scheme should aim to accelerate progress towards a transformational change in prevention, diagnosis, treatment, or care for people affected by blood cancer.